Browse Clinical Trials (1003 trials open to new patients)

Abnormal DNA Repair (1 in progress, 1 open to new patients)
Acinar Cell Carcinoma (1 in progress, 1 open to new patients)
Acinic Cell Carcinoma (1 in progress, 1 open to new patients)
Acoustic Neuroma (2 in progress, 2 open to new patients)
Acute Kidney Injury (1 in progress, 1 open to new patients)
Acute Lymphoblastic Leukemia (31 in progress, 31 open to new patients)
Acute Myeloid Leukemia (54 in progress, 54 open to new patients)
Additional Indications Below for Module 4 and 5 (1 in progress, 1 open to new patients)
Adenocarcinoma (2 in progress, 2 open to new patients)
Adenocarcinoma of the Gastroesophageal Junction (1 in progress, 1 open to new patients)
Adenocarcinoma of the Rectum (1 in progress, 1 open to new patients)
Adenoid Cystic Carcinoma (3 in progress, 3 open to new patients)
Adenoma (1 in progress, 1 open to new patients)
Adnexal Carcinoma (1 in progress, 1 open to new patients)
Adolescent Behavior (1 in progress, 1 open to new patients)
Adrenal Cortical Carcinoma (1 in progress, 1 open to new patients)
Adrenal Gland Pheochromocytoma (2 in progress, 2 open to new patients)
Adrenal Insufficiency (1 in progress, 1 open to new patients)
Adrenocortical Carcinoma (1 in progress, 1 open to new patients)
Advanced/Metastatic Tumors (1 in progress, 1 open to new patients)
AFP Expressing Tumors (1 in progress, 1 open to new patients)
Aggressive Systemic Mastocytosis (1 in progress, 1 open to new patients)
AL Amyloidosis (3 in progress, 3 open to new patients)
ALK Gene Mutation (1 in progress, 1 open to new patients)
ALK Gene Rearrangement (2 in progress, 2 open to new patients)
ALK Gene Translocation (1 in progress, 1 open to new patients)
ALK Positive (1 in progress, 1 open to new patients)
Allogeneic Hematopoietic Cell Transplantation (6 in progress, 6 open to new patients)
Amyotropic Lateral Sclerosis (ALS) (1 in progress, 1 open to new patients)
Anal Basaloid Carcinoma (2 in progress, 2 open to new patients)
Anal Canal Cloacogenic Carcinoma (2 in progress, 2 open to new patients)
Anal Canal Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Anal Canal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Anal Cancer (7 in progress, 7 open to new patients)
Anal Intraepithelial Neoplasia (1 in progress, 1 open to new patients)
Anaplastic Ganglioglioma (1 in progress, 1 open to new patients)
Anaplastic Pleomorphic Xanthoastrocytoma (1 in progress, 1 open to new patients)
Androgen Deprivation Therapy (6 in progress, 6 open to new patients)
Anemia (7 in progress, 7 open to new patients)
Angiolipoma (1 in progress, 1 open to new patients)
Angiosarcoma (2 in progress, 2 open to new patients)
Anhydramnios (1 in progress, 1 open to new patients)
Anterior Cruciate Ligament Injuries (1 in progress, 1 open to new patients)
Antineoplastic Agents (1 in progress, 1 open to new patients)
Apocrine Carcinoma (1 in progress, 1 open to new patients)
Apocrine Neoplasm (1 in progress, 1 open to new patients)
Appendiceal Adenocarcinoma (1 in progress, 1 open to new patients)
Arrythmia (1 in progress, 1 open to new patients)
Arthralgia (1 in progress, 1 open to new patients)
Ascites (1 in progress, 1 open to new patients)
Asthma (2 in progress, 2 open to new patients)
Astrocytoma (26 in progress, 26 open to new patients)
ATM Gene Mutation (1 in progress, 1 open to new patients)
Atrial Septal Defect (1 in progress, 1 open to new patients)
Attention-Deficit/Hyperactivity Disorder (1 in progress, 1 open to new patients)
ATTR Amyloidosis (1 in progress, 1 open to new patients)
Atypical Hyperplasia of the Breast (1 in progress, 1 open to new patients)
Atypical Teratoid Rhabdoid Tumor (2 in progress, 2 open to new patients)
Autism (1 in progress, 1 open to new patients)
Autoimmune Disease (1 in progress, 1 open to new patients)
B-Cell Malignancies (1 in progress, 1 open to new patients)
B Cells--Tumors (1 in progress, 1 open to new patients)
Barrett's Esophagus (1 in progress, 1 open to new patients)
Basal Cell Carcinoma (5 in progress, 5 open to new patients)
Beta Thalassemia (2 in progress, 2 open to new patients)
Biliary Tract Cancer (4 in progress, 4 open to new patients)
Bladder Cancer (33 in progress, 33 open to new patients)
Bladder Small Cell Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Blastic Plasmacytoid Dendritic Cell Neoplasm (1 in progress, 1 open to new patients)
Blood Cancer (1 in progress, 1 open to new patients)
Blood Transfusion Complication (1 in progress, 1 open to new patients)
Bone Cancer (23 in progress, 23 open to new patients)
Bone Disease (1 in progress, 1 open to new patients)
Bone Marrow Disease (1 in progress, 1 open to new patients)
Bone Marrow Transplant (28 in progress, 28 open to new patients)
BRAF V600 Mutation (1 in progress, 1 open to new patients)
BRAF V600E Mutation Present (1 in progress, 1 open to new patients)
Brain and Central Nervous System Tumor (1 in progress, 1 open to new patients)
Brain Cancer (2 in progress, 2 open to new patients)
Brain Metastases (6 in progress, 6 open to new patients)
Brain Tumor (14 in progress, 14 open to new patients)
BRCA 1 Gene Mutation (4 in progress, 4 open to new patients)
BRCA 2 Gene Mutation (3 in progress, 3 open to new patients)
Breast Cancer (111 in progress, 111 open to new patients)
Breast Inflammatory Carcinoma (1 in progress, 1 open to new patients)
Breast Metaplastic Carcinoma (1 in progress, 1 open to new patients)
Breast Pain (1 in progress, 1 open to new patients)
Breast Screening (1 in progress, 1 open to new patients)
Breast Tumor (1 in progress, 1 open to new patients)
BRIP1 Mutation (1 in progress, 1 open to new patients)
Bronchial Neoplasms (1 in progress, 1 open to new patients)
Bronchopulmonary Dysplasia (2 in progress, 2 open to new patients)
Cancer, General (37 in progress, 37 open to new patients)
Cancer, Metastatic (2 in progress, 2 open to new patients)
Cancer of Mouth (1 in progress, 1 open to new patients)
Cancer of Neck (1 in progress, 1 open to new patients)
Cancer Screening (1 in progress, 1 open to new patients)
Cancers Associated With Mesothelin Expression (1 in progress, 1 open to new patients)
CAR T-Cell Therapy (2 in progress, 2 open to new patients)
Carcinoid Tumor (3 in progress, 3 open to new patients)
Carcinoma (4 in progress, 4 open to new patients)
Carcinoma, Bronchogenic (1 in progress, 1 open to new patients)
Carcinoma in Situ (3 in progress, 3 open to new patients)
Carcinoma, Intraductal, Noninfiltrating (1 in progress, 1 open to new patients)
Carcinoma, Ovarian Epithelial (1 in progress, 1 open to new patients)
Carcinoma Transitional Cell (1 in progress, 1 open to new patients)
Cardiotoxicity (2 in progress, 2 open to new patients)
Castration Levels of Testosterone (2 in progress, 2 open to new patients)
Cavernous Hemangioma (1 in progress, 1 open to new patients)
CD19 Positive (1 in progress, 1 open to new patients)
CD20 Positive (2 in progress, 2 open to new patients)
CDK Gene Mutation (1 in progress, 1 open to new patients)
CDK12 Gene Mutation (1 in progress, 1 open to new patients)
Central Nervous System Embryonal Tumor (1 in progress, 1 open to new patients)
Central Nervous System Neoplasms (5 in progress, 5 open to new patients)
Central Nervous System Tumor (6 in progress, 6 open to new patients)
Cerebral Cavernous Malformations (1 in progress, 1 open to new patients)
Cerebral Palsy (1 in progress, 1 open to new patients)
Cervical Adenosquamous Carcinoma (1 in progress, 1 open to new patients)
Cervical Cancer (21 in progress, 21 open to new patients)
Cervical Intraepithelial Neoplasia (1 in progress, 1 open to new patients)
Cervical Squamous Intraepithelial Neoplasia 2 (1 in progress, 1 open to new patients)
CHEK1 Gene Mutation (1 in progress, 1 open to new patients)
CHEK2 Mutation (1 in progress, 1 open to new patients)
Chemoembolization, Therapeutic (1 in progress, 1 open to new patients)
Chemotherapy-induced Thrombocytopenia (2 in progress, 2 open to new patients)
Chest Wall Disease (1 in progress, 1 open to new patients)
Child Behavior (1 in progress, 1 open to new patients)
Child Development (1 in progress, 1 open to new patients)
Cholangiocarcinoma (17 in progress, 17 open to new patients)
Chondrosarcoma (2 in progress, 2 open to new patients)
Chordoma (2 in progress, 2 open to new patients)
Choriocarcinoma (4 in progress, 4 open to new patients)
Choroid Plexus Tumors (1 in progress, 1 open to new patients)
Chronic Granulomatous Disease (1 in progress, 1 open to new patients)
Chronic Illness (1 in progress, 1 open to new patients)
Chronic Kidney Disease (1 in progress, 1 open to new patients)
Chronic Lymphocytic Leukemia (21 in progress, 21 open to new patients)
Chronic Myeloid Leukemia (3 in progress, 3 open to new patients)
Chronic Myelomonocytic Leukemia (4 in progress, 4 open to new patients)
Chronic Rhinosinusitis (1 in progress, 1 open to new patients)
Circulating Tumor DNA (1 in progress, 1 open to new patients)
Cirrhosis (3 in progress, 3 open to new patients)
Coagulation Disorder (1 in progress, 1 open to new patients)
Cognition (1 in progress, 1 open to new patients)
Cognitive Dysfunction (1 in progress, 1 open to new patients)
Cognitive Impairment (1 in progress, 1 open to new patients)
Collecting Duct Carcinoma (2 in progress, 2 open to new patients)
Colon Cancer (14 in progress, 14 open to new patients)
Colon Disease (1 in progress, 1 open to new patients)
Colon Lesion (1 in progress, 1 open to new patients)
Colon Polyps (2 in progress, 2 open to new patients)
Colonoscopy (1 in progress, 1 open to new patients)
Colorectal Adenocarcinomas (1 in progress, 1 open to new patients)
Colorectal Cancer (73 in progress, 73 open to new patients)
Colorectal Disorders (1 in progress, 1 open to new patients)
Colorectal Tumor (9 in progress, 9 open to new patients)
Colostomy Stoma (1 in progress, 1 open to new patients)
Congenital Amegakaryocytic Thrombocytopenia (1 in progress, 1 open to new patients)
Congenital Mesoblastic Nephroma (2 in progress, 2 open to new patients)
Congenital Pure Red Cell Aplasia (1 in progress, 1 open to new patients)
Control (1 in progress, 1 open to new patients)
COVID-19 (5 in progress, 5 open to new patients)
Cutaneous T-Cell Lymphoma (1 in progress, 1 open to new patients)
Cylindrocarcinoma (1 in progress, 1 open to new patients)
Cystic Nephroma (1 in progress, 1 open to new patients)
Cytomegalovirus (1 in progress, 1 open to new patients)
Deafness (1 in progress, 1 open to new patients)
Death (1 in progress, 1 open to new patients)
Deglutition Disorders (2 in progress, 2 open to new patients)
Delirium (1 in progress, 1 open to new patients)
Dental Plaque (1 in progress, 1 open to new patients)
Depression (1 in progress, 1 open to new patients)
Desmoid Tumor (4 in progress, 4 open to new patients)
Desmoplastic Small Round Cell Tumors (1 in progress, 1 open to new patients)
Diffuse Large B-Cell Lymphoma (25 in progress, 25 open to new patients)
Digestive System Tumor (1 in progress, 1 open to new patients)
Digital Papillary Adenocarcinoma (1 in progress, 1 open to new patients)
DIPG (6 in progress, 6 open to new patients)
Disorders of the Immune System (1 in progress, 1 open to new patients)
DNA Damage Response Gene Mutation (1 in progress, 1 open to new patients)
DNA Repair Gene Mutation (1 in progress, 1 open to new patients)
Dock 8 Deficiency (1 in progress, 1 open to new patients)
Down Syndrome (3 in progress, 3 open to new patients)
Dysplasia (6 in progress, 6 open to new patients)
EBV-Positive DLBCL (1 in progress, 1 open to new patients)
EBV Related PTCL (1 in progress, 1 open to new patients)
EBV-Related PTLD (1 in progress, 1 open to new patients)
Economic Problems (1 in progress, 1 open to new patients)
Ectomesenchymoma (1 in progress, 1 open to new patients)
Edema (1 in progress, 1 open to new patients)
EGFR Activating Mutation (1 in progress, 1 open to new patients)
EGFR Amplification (1 in progress, 1 open to new patients)
EGFR C797S (1 in progress, 1 open to new patients)
EGFR Exon 19 Deletion (1 in progress, 1 open to new patients)
EGFR Gene Mutation (2 in progress, 2 open to new patients)
EGFR L858R (1 in progress, 1 open to new patients)
EGFR T790M (1 in progress, 1 open to new patients)
EGFRI Induced Acneiform Lesions (1 in progress, 1 open to new patients)
Embryonal Carcinoma (1 in progress, 1 open to new patients)
End of Life (1 in progress, 1 open to new patients)
Endocrine Mucin-Producing Sweat Gland Carcinoma (1 in progress, 1 open to new patients)
Endometrial Cancer (20 in progress, 20 open to new patients)
Endometrial Dedifferentiated Carcinoma (1 in progress, 1 open to new patients)
Endometrial Mixed Cell Adenocarcinoma (1 in progress, 1 open to new patients)
Endometrial Serous Adenocarcinoma (1 in progress, 1 open to new patients)
Endometrial Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Ependymoma (10 in progress, 10 open to new patients)
Epilepsy (1 in progress, 1 open to new patients)
Epithelial Tumor (3 in progress, 3 open to new patients)
Epithelioid Sarcoma (1 in progress, 1 open to new patients)
Epstein Barr Virus (5 in progress, 5 open to new patients)
Erythroleukoplakia (1 in progress, 1 open to new patients)
Esophageal Adenocarcinomas (1 in progress, 1 open to new patients)
Esophageal Cancer (20 in progress, 20 open to new patients)
Esophageal Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Esophageal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Esophagogastric Junction (1 in progress, 1 open to new patients)
Essential Thrombocytosis (1 in progress, 1 open to new patients)
Estrogen Receptor Negative (1 in progress, 1 open to new patients)
Estrogen Receptor Positive (1 in progress, 1 open to new patients)
Ewing Sarcoma (11 in progress, 11 open to new patients)
Extensive Stage Lung Small Cell Carcinoma (4 in progress, 4 open to new patients)
Extragonadal Embryonal Carcinoma (1 in progress, 1 open to new patients)
Extraocular Cutaneous Sebaceous Carcinoma (1 in progress, 1 open to new patients)
Eye Cancer (1 in progress, 1 open to new patients)
Fallopian Tube Cancer (12 in progress, 12 open to new patients)
FANCA Gene Mutation (1 in progress, 1 open to new patients)
FANCD2 Gene Mutation (1 in progress, 1 open to new patients)
FANCL Gene Mutation (1 in progress, 1 open to new patients)
Fertility Preservation (1 in progress, 1 open to new patients)
Fetal Renal Anomaly (1 in progress, 1 open to new patients)
FGFR 1 High Amplification (1 in progress, 1 open to new patients)
FGFR2 Amplification (2 in progress, 2 open to new patients)
FGFR2 Gene Activation (1 in progress, 1 open to new patients)
FGFR2 Gene Fusion/Rearrangement (1 in progress, 1 open to new patients)
FGFR2 Gene Mutation (2 in progress, 2 open to new patients)
FGFR2 Gene Translocation (1 in progress, 1 open to new patients)
Fibrolamellar Carcinoma (2 in progress, 2 open to new patients)
Fibromyxoid Tumor (1 in progress, 1 open to new patients)
Fibrosis (1 in progress, 1 open to new patients)
Gallbladder Cancer (2 in progress, 2 open to new patients)
Gallbladder Carcinoma (3 in progress, 3 open to new patients)
Gallbladder Neoplasms (1 in progress, 1 open to new patients)
Ganglioneuroblastoma (3 in progress, 3 open to new patients)
Gastric Adenocarcinomas (1 in progress, 1 open to new patients)
Gastric Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Gastric Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Gastric/Upper Gastrointestinal Cancer (1 in progress, 1 open to new patients)
Gastroesophageal Junction Adenocarcinoma (16 in progress, 16 open to new patients)
Gastroesophageal Junction Cancer (20 in progress, 20 open to new patients)
Gastrointestinal Cancer (1 in progress, 1 open to new patients)
Gastrointestinal Neoplasms (2 in progress, 2 open to new patients)
Gastrointestinal Stromal Tumor (2 in progress, 2 open to new patients)
Gastrointestinal Tract Cancers (1 in progress, 1 open to new patients)
Gastrointestinal Tumors (1 in progress, 1 open to new patients)
GEN1 Gene Mutation (1 in progress, 1 open to new patients)
Genetic Diseases (1 in progress, 1 open to new patients)
Genetic Predisposition (1 in progress, 1 open to new patients)
Genetic Predisposition to Disease (1 in progress, 1 open to new patients)
Genital Neoplasms, Male (1 in progress, 1 open to new patients)
Genitourinary Cancer (2 in progress, 2 open to new patients)
Genitourinary System Carcinoma (1 in progress, 1 open to new patients)
Germ Cell Tumor (13 in progress, 13 open to new patients)
Gestational Trophoblastic Tumor (1 in progress, 1 open to new patients)
Giant Cell Carcinoma (1 in progress, 1 open to new patients)
Giant Cell Tumor of Bone (1 in progress, 1 open to new patients)
Giant Cell Tumor of Tendon Sheath (1 in progress, 1 open to new patients)
Glioblastoma (24 in progress, 24 open to new patients)
Glioma (52 in progress, 52 open to new patients)
Gliosarcoma (1 in progress, 1 open to new patients)
Gliosis (1 in progress, 1 open to new patients)
Graft Failure (1 in progress, 1 open to new patients)
Graft Versus Host Disease (4 in progress, 4 open to new patients)
Growth Failure (1 in progress, 1 open to new patients)
Gut Microbiome (1 in progress, 1 open to new patients)
Gynecologic Cancer (1 in progress, 1 open to new patients)
Head and Neck Cancer (47 in progress, 47 open to new patients)
Head and Neck Lymphedema (1 in progress, 1 open to new patients)
Head and Neck Squamous Cell Carcinoma (33 in progress, 33 open to new patients)
Head and Neck Tumor (3 in progress, 3 open to new patients)
Health Disparities (1 in progress, 1 open to new patients)
Health Knowledge, Attitudes, Practice (1 in progress, 1 open to new patients)
Heart Failure (2 in progress, 2 open to new patients)
Hematologic Disease (2 in progress, 2 open to new patients)
Hematologic Malignancy (19 in progress, 19 open to new patients)
Hematologic Neoplasms (3 in progress, 3 open to new patients)
Hematopoietic and Lymphoid Cell Neoplasm (4 in progress, 4 open to new patients)
Hematopoietic and Lymphoid System Neoplasm (2 in progress, 2 open to new patients)
Hematopoietic Cell Transplantation (20 in progress, 20 open to new patients)
Hematopoietic System--Cancer (1 in progress, 1 open to new patients)
Hemimegalencephaly (1 in progress, 1 open to new patients)
Hemispheric (1 in progress, 1 open to new patients)
Hemophilia (1 in progress, 1 open to new patients)
Hepatitis B (1 in progress, 1 open to new patients)
Hepatitis C (2 in progress, 2 open to new patients)
Hepatoblastoma (8 in progress, 8 open to new patients)
Hepatocellular Cancer (2 in progress, 2 open to new patients)
Hepatocellular Carcinoma (30 in progress, 30 open to new patients)
Hepatotoxicity (1 in progress, 1 open to new patients)
HER2 (38 in progress, 38 open to new patients)
Hidradenocarcinoma (1 in progress, 1 open to new patients)
High Blood Pressure (1 in progress, 1 open to new patients)
Histiocytic and Dendritic Cell Neoplasm (1 in progress, 1 open to new patients)
Histiocytic Disorders (1 in progress, 1 open to new patients)
HIV/AIDS (9 in progress, 9 open to new patients)
HLA-A*0201 Positive Cells Present (1 in progress, 1 open to new patients)
Hodgkin's Lymphoma (47 in progress, 47 open to new patients)
Homologous Recombination Deficiency (1 in progress, 1 open to new patients)
Hormone Receptor Negative Tumor (1 in progress, 1 open to new patients)
Hormone Receptor Positive Tumor (1 in progress, 1 open to new patients)
HRAS Gene Mutation (1 in progress, 1 open to new patients)
Human Papillomavirus (9 in progress, 9 open to new patients)
Hyperphosphatemia (1 in progress, 1 open to new patients)
Hypokalemia (1 in progress, 1 open to new patients)
Hypopharyngeal Carcinoma (1 in progress, 1 open to new patients)
IDH1 Gene Mutation (1 in progress, 1 open to new patients)
IDH2 Gene Mutation (1 in progress, 1 open to new patients)
IL13RA2 Positive (1 in progress, 1 open to new patients)
Immunodeficiency (3 in progress, 3 open to new patients)
Immunotherapy (35 in progress, 35 open to new patients)
Indeterminate Lesions of Eye (1 in progress, 1 open to new patients)
Infantile Fibrosarcoma (1 in progress, 1 open to new patients)
Infiltrating Bladder Mixed Carcinoma (1 in progress, 1 open to new patients)
Infusion Reaction (2 in progress, 2 open to new patients)
Inherited Abnormalities of Platelets (1 in progress, 1 open to new patients)
Inherited Disorders of Metabolism (1 in progress, 1 open to new patients)
INI1 Negative Malignant Tumors (With PI Approval) (1 in progress, 1 open to new patients)
Insomnia (1 in progress, 1 open to new patients)
Intermediate Grade Lung Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Intermediate/High-Risk MDS (1 in progress, 1 open to new patients)
Intestinal Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Intracranial Neoplasm (1 in progress, 1 open to new patients)
Intraductal Papillary Mucosal Neoplasm (1 in progress, 1 open to new patients)
Juvenile Myelomonocytic Leukemia (1 in progress, 1 open to new patients)
Juvenile Xanthogranuloma (1 in progress, 1 open to new patients)
Kaposi's Sarcoma (4 in progress, 4 open to new patients)
Kawasaki Disease (1 in progress, 1 open to new patients)
Keratoacanthoma (1 in progress, 1 open to new patients)
Kidney Cancer (29 in progress, 29 open to new patients)
Kidney Disease (1 in progress, 1 open to new patients)
Kidney Medullary Carcinoma (2 in progress, 2 open to new patients)
Kidney Neoplasm (3 in progress, 3 open to new patients)
Kidney Oncocytoma (1 in progress, 1 open to new patients)
Kidney Transplant (1 in progress, 1 open to new patients)
KRAS G12D (1 in progress, 1 open to new patients)
KRAS G12R (1 in progress, 1 open to new patients)
KRAS Gene Mutation (1 in progress, 1 open to new patients)
KRAS Mutation-Related Tumors (1 in progress, 1 open to new patients)
KRAS Protein Variant (1 in progress, 1 open to new patients)
Langerhans Cell Histiocytosis (8 in progress, 8 open to new patients)
Laryngeal Cancer (1 in progress, 1 open to new patients)
Leiomyosarcoma (5 in progress, 5 open to new patients)
Leukemia (102 in progress, 102 open to new patients)
Leukoplakia (1 in progress, 1 open to new patients)
Limited Stage Lung Small Cell Carcinoma (1 in progress, 1 open to new patients)
Lip and Oral Cavity Cancer (2 in progress, 2 open to new patients)
Liposarcoma (3 in progress, 3 open to new patients)
Liver Cancer (35 in progress, 35 open to new patients)
Liver Cirrhoses (1 in progress, 1 open to new patients)
Liver Disease (1 in progress, 1 open to new patients)
Liver Transplant (2 in progress, 2 open to new patients)
Locally Advanced Chordoma (1 in progress, 1 open to new patients)
Locally Advanced Lung Non-Small Cell Carcinoma (1 in progress, 1 open to new patients)
Locally Advanced Malignant Solid Neoplasm (2 in progress, 2 open to new patients)
Locally Advanced Thymic Carcinoma (1 in progress, 1 open to new patients)
Low Grade Lung Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Low Grade Serous Carcinoma (1 in progress, 1 open to new patients)
Lower Urinary Tract Obstructive Syndrome (1 in progress, 1 open to new patients)
Lung Adenosquamous Carcinoma (1 in progress, 1 open to new patients)
Lung Cancer (130 in progress, 130 open to new patients)
Lung Diseases (1 in progress, 1 open to new patients)
Lung Hypoplasia (1 in progress, 1 open to new patients)
Lung Large Cell Carcinoma (1 in progress, 1 open to new patients)
Lung Metastases (1 in progress, 1 open to new patients)
Lung Non-Small Cell Cancer (1 in progress, 1 open to new patients)
Lung Non-Small Cell Carcinoma (9 in progress, 9 open to new patients)
Lung Non-Small Cell Squamous Carcinoma (1 in progress, 1 open to new patients)
Lung Non-Squamous Non-Small Cell Carcinoma (5 in progress, 5 open to new patients)
Lung Sarcomatoid Carcinoma (1 in progress, 1 open to new patients)
Lung Small Cell Carcinoma (2 in progress, 2 open to new patients)
Lung Tumor (3 in progress, 3 open to new patients)
Lymphedema (1 in progress, 1 open to new patients)
Lymphohistiocytosis, Hemophagocytic (1 in progress, 1 open to new patients)
Lymphoid Malignancies (1 in progress, 1 open to new patients)
Lymphoma (102 in progress, 102 open to new patients)
Lymphoproliferative Disorders (5 in progress, 5 open to new patients)
Macrocephaly (1 in progress, 1 open to new patients)
Major Salivary Gland Cancer (1 in progress, 1 open to new patients)
Major Salivary Gland Carcinoma (1 in progress, 1 open to new patients)
Malignancies (2 in progress, 2 open to new patients)
Malignant Adrenal Gland Neoplasm (1 in progress, 1 open to new patients)
Malignant Central Nervous System Neoplasm (1 in progress, 1 open to new patients)
Malignant Germ Cell Neoplasm (1 in progress, 1 open to new patients)
Malignant Hepatobiliary Neoplasm (1 in progress, 1 open to new patients)
Malignant Neoplasm (34 in progress, 34 open to new patients)
Malignant Neoplastic Disease (1 in progress, 1 open to new patients)
Malignant Odontogenic Neoplasm (1 in progress, 1 open to new patients)
Malignant Peripheral Nerve Sheath Tumor (3 in progress, 3 open to new patients)
Malignant Pleural Neoplasm (1 in progress, 1 open to new patients)
Malignant Rhabdoid Tumor (1 in progress, 1 open to new patients)
Malignant Solid Neoplasm (24 in progress, 24 open to new patients)
Malignant Sweat Gland Neoplasm (1 in progress, 1 open to new patients)
Malignant Testicular Sex Cord-Stromal Tumor (1 in progress, 1 open to new patients)
Malignant Thymus Neoplasm (1 in progress, 1 open to new patients)
Malignant Uterine Neoplasm (1 in progress, 1 open to new patients)
Mantle Cell Lymphoma (18 in progress, 18 open to new patients)
MDM2 Gene Mutation (1 in progress, 1 open to new patients)
Medulloblastoma (12 in progress, 12 open to new patients)
Melanoma (52 in progress, 52 open to new patients)
Meningioma (6 in progress, 6 open to new patients)
Menopause (1 in progress, 1 open to new patients)
Menorrhagia (1 in progress, 1 open to new patients)
Merkel Cell Carcinoma (7 in progress, 7 open to new patients)
Mesoblastic Nephroma (2 in progress, 2 open to new patients)
Mesothelioma (5 in progress, 5 open to new patients)
MET Gene Alterations (1 in progress, 1 open to new patients)
Metanephric Adenofibroma (1 in progress, 1 open to new patients)
Metanephric Adenoma (1 in progress, 1 open to new patients)
Metanephric Stromal Tumor (1 in progress, 1 open to new patients)
Metanephric Tumor (1 in progress, 1 open to new patients)
Metastatic Adenocarcinoma (1 in progress, 1 open to new patients)
Metastatic Cancer (11 in progress, 11 open to new patients)
Metastatic Castration-Resistant Prostate Cancer (28 in progress, 28 open to new patients)
Metastatic Chordoma (1 in progress, 1 open to new patients)
Metastatic Gallbladder Carcinoma (1 in progress, 1 open to new patients)
Metastatic Genitourinary System Carcinoma (1 in progress, 1 open to new patients)
Metastatic Lung Adenosquamous Carcinoma (1 in progress, 1 open to new patients)
Metastatic Lung Non-Small Cell Carcinoma (3 in progress, 3 open to new patients)
Metastatic Lung Small Cell Carcinoma (1 in progress, 1 open to new patients)
Metastatic Malignant Solid Neoplasm (7 in progress, 7 open to new patients)
Metastatic Neoplasm (1 in progress, 1 open to new patients)
Metastatic Osteosarcoma (1 in progress, 1 open to new patients)
Metastatic Prostate Small Cell Carcinoma (1 in progress, 1 open to new patients)
Metastatic Small Intestinal Carcinoma (1 in progress, 1 open to new patients)
Metastatic Spine Tumor (1 in progress, 1 open to new patients)
Metastatic Thymic Carcinoma (1 in progress, 1 open to new patients)
Metastatic Thymic Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Microcystic Adnexal Carcinoma (1 in progress, 1 open to new patients)
Microsatellite Instability (4 in progress, 4 open to new patients)
Mindfulness (1 in progress, 1 open to new patients)
Minimal Residual Disease (1 in progress, 1 open to new patients)
Mismatch Repair Deficiency (1 in progress, 1 open to new patients)
Mixed Müllerian Tumor (1 in progress, 1 open to new patients)
Mole (1 in progress, 1 open to new patients)
Monoclonal Antibody (1 in progress, 1 open to new patients)
Movement Disorders (1 in progress, 1 open to new patients)
MPNST (1 in progress, 1 open to new patients)
MRI (2 in progress, 2 open to new patients)
Mucinous Adenocarcinoma (1 in progress, 1 open to new patients)
Mucinous Cyst (1 in progress, 1 open to new patients)
Mucinous Cystadenocarcinoma (1 in progress, 1 open to new patients)
Mucoepidermoid Carcinoma (1 in progress, 1 open to new patients)
Mucositis (1 in progress, 1 open to new patients)
Multicystic Dysplastic Kidney (1 in progress, 1 open to new patients)
Multiple Myeloma (42 in progress, 42 open to new patients)
Myasthenia Gravis (2 in progress, 2 open to new patients)
Mycosis Fungoides (2 in progress, 2 open to new patients)
Myelodyspastic Syndrome (1 in progress, 1 open to new patients)
Myelodysplastic Syndrome (15 in progress, 15 open to new patients)
Myelofibrosis (2 in progress, 2 open to new patients)
Myeloid Malignancy (1 in progress, 1 open to new patients)
Myeloid Neoplasms With Germline GATA2 Mutation (1 in progress, 1 open to new patients)
Myeloid or Lymphoid Neoplasms (MLN) (1 in progress, 1 open to new patients)
Myeloma, Plasma-Cell (1 in progress, 1 open to new patients)
Myelomatosis (1 in progress, 1 open to new patients)
Myeloproliferative Disorders (1 in progress, 1 open to new patients)
Myeloproliferative Neoplasms (8 in progress, 8 open to new patients)
Myxofibrosarcoma (2 in progress, 2 open to new patients)
Nasal Cavity Adenocarcinoma (1 in progress, 1 open to new patients)
Nasal Cavity Carcinoma (1 in progress, 1 open to new patients)
Nasal Polyps (1 in progress, 1 open to new patients)
Nasopharyngeal Cancer (5 in progress, 5 open to new patients)
Nasopharyngeal Papillary Adenocarcinoma (1 in progress, 1 open to new patients)
Nasopharyngeal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Nausea (1 in progress, 1 open to new patients)
NBN Gene Mutation (1 in progress, 1 open to new patients)
Necrotizing Enterocolitis (1 in progress, 1 open to new patients)
Neoplasms (21 in progress, 21 open to new patients)
Neoplasm Metastasis (1 in progress, 1 open to new patients)
Neoplasms, Liver (2 in progress, 2 open to new patients)
Neoplasms, Nerve Tissue (1 in progress, 1 open to new patients)
Nephrotoxicity (1 in progress, 1 open to new patients)
Neuroblastoma (23 in progress, 23 open to new patients)
Neurocognitive Function (1 in progress, 1 open to new patients)
Neuroectodermal Tumors (1 in progress, 1 open to new patients)
Neuroendocrine Carcinoma/Small Cell Carcinoma (1 in progress, 1 open to new patients)
Neuroendocrine Neoplasm (3 in progress, 3 open to new patients)
Neuroendocrine Tumor (4 in progress, 4 open to new patients)
Neurofibromatosis (4 in progress, 4 open to new patients)
Neuropathy (1 in progress, 1 open to new patients)
NF2 Gene Mutation (1 in progress, 1 open to new patients)
NFE2L2 Gene Mutation (1 in progress, 1 open to new patients)
NMIBC (1 in progress, 1 open to new patients)
Nodule Solitary Pulmonary (1 in progress, 1 open to new patients)
Non-Hodgkin Lymphoma (40 in progress, 40 open to new patients)
Non-small Cell Lunch Cancer (1 in progress, 1 open to new patients)
Non-Small Cell Lung Cancer (111 in progress, 111 open to new patients)
Non-urothelial Bladder (1 in progress, 1 open to new patients)
Non-urothelial Upper Tract (1 in progress, 1 open to new patients)
Nonalcoholic Steatohepatitis (1 in progress, 1 open to new patients)
NRAS G12D (1 in progress, 1 open to new patients)
NRAS G12R (1 in progress, 1 open to new patients)
NRG1 Fusion (1 in progress, 1 open to new patients)
NTRK Family Gene Mutation (1 in progress, 1 open to new patients)
NY-ESO-1 Positive (1 in progress, 1 open to new patients)
Obesity (3 in progress, 3 open to new patients)
Opioid Use (1 in progress, 1 open to new patients)
Oral Cancer (1 in progress, 1 open to new patients)
Oral Cavity Carcinoma (1 in progress, 1 open to new patients)
Oral Leukoplakia (1 in progress, 1 open to new patients)
Oropharyngeal Cancer (9 in progress, 9 open to new patients)
Oropharyngeal Dysphagia (2 in progress, 2 open to new patients)
Oropharyngeal (p16-Negative) Carcinoma (1 in progress, 1 open to new patients)
Oropharyngeal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Oropharynx Cancer (2 in progress, 2 open to new patients)
Oropharynx Cancer, Metastatic (1 in progress, 1 open to new patients)
Oropharynx Cancer, Recurrent (1 in progress, 1 open to new patients)
Ossifying Renal Tumor of Infancy (1 in progress, 1 open to new patients)
Osteoarthritis (1 in progress, 1 open to new patients)
Osteoid Osteoma (1 in progress, 1 open to new patients)
Osteosarcoma (17 in progress, 17 open to new patients)
Osteosarcoma Metastatic (1 in progress, 1 open to new patients)
Osteosarcoma Recurrent (2 in progress, 2 open to new patients)
Ototoxicity (1 in progress, 1 open to new patients)
Ovarian Cancer (43 in progress, 43 open to new patients)
Ovarian Embryonal Carcinoma (1 in progress, 1 open to new patients)
Ovarian Epithelial Cancer (1 in progress, 1 open to new patients)
Ovarian Low Grade Serous Adenocarcinoma (1 in progress, 1 open to new patients)
Ovarian Serous Adenocarcinoma (4 in progress, 4 open to new patients)
Ovarian Tumor (3 in progress, 3 open to new patients)
Ovary Cancer (1 in progress, 1 open to new patients)
Overactive Bladder (1 in progress, 1 open to new patients)
P53 Mutation (1 in progress, 1 open to new patients)
Paget's Disease (2 in progress, 2 open to new patients)
Pain (2 in progress, 2 open to new patients)
Pancreas Cyst (1 in progress, 1 open to new patients)
Pancreatic Acinar Cell Carcinoma (1 in progress, 1 open to new patients)
Pancreatic Cancer (45 in progress, 45 open to new patients)
Pancreatic Cyst (2 in progress, 2 open to new patients)
Pancreatic Diseases (1 in progress, 1 open to new patients)
Pancreatic Ductal Adenocarcinoma (5 in progress, 5 open to new patients)
Pancreatic IPMN (1 in progress, 1 open to new patients)
Pancreatic Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Pancreatobiliary Carcinoma (1 in progress, 1 open to new patients)
Papillary Adenocarcinoma (1 in progress, 1 open to new patients)
Papillary Craniopharyngioma (1 in progress, 1 open to new patients)
Paranasal Sinus Adenocarcinoma (1 in progress, 1 open to new patients)
Paranasal Sinus Carcinoma (1 in progress, 1 open to new patients)
Parathyroid Gland Carcinoma (1 in progress, 1 open to new patients)
Parkinson's Disease (1 in progress, 1 open to new patients)
Parotid Gland Cancer (1 in progress, 1 open to new patients)
Paroxysmal Nocturnal Hemoglobinuria (1 in progress, 1 open to new patients)
PEComa (1 in progress, 1 open to new patients)
Penile Cancer (2 in progress, 2 open to new patients)
Penile Carcinoma (1 in progress, 1 open to new patients)
Peritoneal Cancer (11 in progress, 11 open to new patients)
Peritoneal Carcinomatosis (1 in progress, 1 open to new patients)
Pheochromocytoma (1 in progress, 1 open to new patients)
Philadelphia Chromosome Positive (1 in progress, 1 open to new patients)
PI3K Gene Mutation (1 in progress, 1 open to new patients)
Pigmented Villonodular Synovitis (1 in progress, 1 open to new patients)
Pineal Region Tumors (1 in progress, 1 open to new patients)
Plasmacytoma (1 in progress, 1 open to new patients)
Pneumonia (2 in progress, 2 open to new patients)
Polymicrogyria (1 in progress, 1 open to new patients)
Polyp (1 in progress, 1 open to new patients)
Porocarcinoma (1 in progress, 1 open to new patients)
Post-Transplant Lymphoproliferative Disease (2 in progress, 2 open to new patients)
Postmenopausal (1 in progress, 1 open to new patients)
Postneoadjuvant Therapy (2 in progress, 2 open to new patients)
Postoperative Pain (2 in progress, 2 open to new patients)
Potter Syndrome (1 in progress, 1 open to new patients)
Precancerous Condition (1 in progress, 1 open to new patients)
Preleukemia (1 in progress, 1 open to new patients)
Premature Infant (1 in progress, 1 open to new patients)
Preoperative Aerobic Training (1 in progress, 1 open to new patients)
Primary Cutaneous Mucinous Carcinoma (1 in progress, 1 open to new patients)
Primary Hyperaldosteronism (1 in progress, 1 open to new patients)
Primary Myelofibrosis (2 in progress, 2 open to new patients)
Primitive Neuroectodermal Tumor (7 in progress, 7 open to new patients)
Progesterone Receptor Negative (1 in progress, 1 open to new patients)
Progressive Disease (1 in progress, 1 open to new patients)
Prostate Cancer (92 in progress, 92 open to new patients)
Prostate Disease (1 in progress, 1 open to new patients)
Prostate Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Prostate Small Cell Carcinoma (1 in progress, 1 open to new patients)
Protein Kinase Inhibitors (1 in progress, 1 open to new patients)
PSA Progression (1 in progress, 1 open to new patients)
Pseudomyxoma Peritonei (2 in progress, 2 open to new patients)
PTEN Hamartoma Tumor Syndrome (1 in progress, 1 open to new patients)
Pulmonary Arterial Hypertension (1 in progress, 1 open to new patients)
Pulmonary Disease (2 in progress, 2 open to new patients)
Pulmonary Hypertension (1 in progress, 1 open to new patients)
Quality of Life (3 in progress, 3 open to new patients)
RAD51 Gene Mutation (1 in progress, 1 open to new patients)
RAD51C Gene Mutation (1 in progress, 1 open to new patients)
Rare Disorder (1 in progress, 1 open to new patients)
RAS Mutation (1 in progress, 1 open to new patients)
Rasmussen Encephalitis (1 in progress, 1 open to new patients)
Rectal Cancer (10 in progress, 10 open to new patients)
Rectal Diseases (1 in progress, 1 open to new patients)
Rectal Prolapse (1 in progress, 1 open to new patients)
Refractory Adrenal Gland Pheochromocytoma (1 in progress, 1 open to new patients)
Refractory Germ-cell (1 in progress, 1 open to new patients)
Refractory Lung Non-Small Cell Carcinoma (1 in progress, 1 open to new patients)
Refractory Lung Small Cell Carcinoma (1 in progress, 1 open to new patients)
Refractory Malignant Solid Neoplasm (8 in progress, 8 open to new patients)
Refractory Neoplasm (1 in progress, 1 open to new patients)
Refractory Osteosarcoma (7 in progress, 7 open to new patients)
Refractory Tumor (1 in progress, 1 open to new patients)
Relapsed Osteosarcoma (1 in progress, 1 open to new patients)
Relapsed Solid Neoplasm (1 in progress, 1 open to new patients)
Renal Calculi (1 in progress, 1 open to new patients)
Renal Cell Carcinoma (21 in progress, 21 open to new patients)
Renal Mass (1 in progress, 1 open to new patients)
Renal Pelvis and Ureter Cancer (1 in progress, 1 open to new patients)
Renal Pelvis Cancer (2 in progress, 2 open to new patients)
Renal Pelvis Neoplasms (1 in progress, 1 open to new patients)
Resectable Lung Non-Small Cell Carcinoma (1 in progress, 1 open to new patients)
Resectable Osteosarcoma (1 in progress, 1 open to new patients)
Residual Cancer (1 in progress, 1 open to new patients)
Respiratory Tract Disease (1 in progress, 1 open to new patients)
Respiratory Tract Neoplasms (1 in progress, 1 open to new patients)
RET Gene Mutation (1 in progress, 1 open to new patients)
Rhabdoid Tumor (11 in progress, 11 open to new patients)
Rhabdomyosarcoma (13 in progress, 13 open to new patients)
Richter's Syndrome (1 in progress, 1 open to new patients)
ROS1 Gene Mutation (1 in progress, 1 open to new patients)
ROS1 Gene Rearrangement (1 in progress, 1 open to new patients)
Salivary Cancer (1 in progress, 1 open to new patients)
Salivary Duct Carcinoma (1 in progress, 1 open to new patients)
Salivary Gland Cancer (3 in progress, 3 open to new patients)
Salivary Gland Carcinoma (2 in progress, 2 open to new patients)
Salivary Gland Tumor (1 in progress, 1 open to new patients)
Sarcoma (36 in progress, 36 open to new patients)
Schwannoma (2 in progress, 2 open to new patients)
Sdh (1 in progress, 1 open to new patients)
Sedentary Behavior (1 in progress, 1 open to new patients)
Sedentary Time (1 in progress, 1 open to new patients)
Seizures (1 in progress, 1 open to new patients)
Seminal Vesicle Adenocarcinoma (1 in progress, 1 open to new patients)
Seminoma (4 in progress, 4 open to new patients)
Sentinel Lymph Node Biopsy (1 in progress, 1 open to new patients)
Serous Cystadenocarcinoma (1 in progress, 1 open to new patients)
Sessile Serrated Adenoma (1 in progress, 1 open to new patients)
Sexually Transmitted Infections (1 in progress, 1 open to new patients)
Sezary Disease (2 in progress, 2 open to new patients)
Shingles (1 in progress, 1 open to new patients)
Shwachman-Diamond Syndrome (1 in progress, 1 open to new patients)
Sickle Cell Anemia (9 in progress, 9 open to new patients)
Signet Ring Cell Carcinoma (1 in progress, 1 open to new patients)
Skin Basosquamous Cell Carcinoma (1 in progress, 1 open to new patients)
Skin Cancer/Melanoma (55 in progress, 55 open to new patients)
Skin Infection (1 in progress, 1 open to new patients)
Skin Lesion (2 in progress, 2 open to new patients)
Sleep Disorders (1 in progress, 1 open to new patients)
Small Cell Carcinoma (1 in progress, 1 open to new patients)
Small Cell Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Small Intestinal Adenocarcinoma (1 in progress, 1 open to new patients)
Small Lymphocytic Lymphoma (15 in progress, 15 open to new patients)
Smoking Cessation (1 in progress, 1 open to new patients)
Soft Tissue Fibrosarcoma (1 in progress, 1 open to new patients)
Soft Tissue Sarcoma (16 in progress, 16 open to new patients)
Solid Malignancies (1 in progress, 1 open to new patients)
Solid Neoplasm (4 in progress, 4 open to new patients)
Solid Organ Transplant Complications (2 in progress, 2 open to new patients)
Solid Tumor (157 in progress, 157 open to new patients)
Spinal Column Tumor (1 in progress, 1 open to new patients)
Spinal Cord Injury (1 in progress, 1 open to new patients)
Spindle Cell Neoplasm (1 in progress, 1 open to new patients)
Spiradenocarcinoma (1 in progress, 1 open to new patients)
Squamoid Eccrine Ductal Carcinoma (1 in progress, 1 open to new patients)
Squamous Cell Carcinoma (59 in progress, 59 open to new patients)
Squamous Intraepithelial Neoplasia (1 in progress, 1 open to new patients)
Squamous Non-Small Cell Neoplasm of Lung (1 in progress, 1 open to new patients)
SSC (1 in progress, 1 open to new patients)
Steatohepatitis (1 in progress, 1 open to new patients)
Stomach Cancer (36 in progress, 36 open to new patients)
Stroke (1 in progress, 1 open to new patients)
Stromal Neoplasm (1 in progress, 1 open to new patients)
Sturge-Weber Syndrome (1 in progress, 1 open to new patients)
Surgery (1 in progress, 1 open to new patients)
Surgery--Complications (1 in progress, 1 open to new patients)
Sweat Gland Carcinoma (1 in progress, 1 open to new patients)
Synovial Sarcoma (3 in progress, 3 open to new patients)
Systemic Mastocytosis (AdvSM) (1 in progress, 1 open to new patients)
T Cell Lymphoma (6 in progress, 6 open to new patients)
Taste Dysfunction (1 in progress, 1 open to new patients)
Tenosynovial Giant Cell Tumor (2 in progress, 2 open to new patients)
Tenosynovial Giant Cell Tumor, Diffuse (1 in progress, 1 open to new patients)
Tenosynovial Giant Cell Tumor, Localized (1 in progress, 1 open to new patients)
Teratoma (5 in progress, 5 open to new patients)
Testicular Cancer (4 in progress, 4 open to new patients)
Testicular Tumor (1 in progress, 1 open to new patients)
Thalassemia (1 in progress, 1 open to new patients)
Thoracic Neoplasms (1 in progress, 1 open to new patients)
Thymic Carcinoma (1 in progress, 1 open to new patients)
Thyroid Cancer (10 in progress, 10 open to new patients)
Thyroid Gland Nodule (1 in progress, 1 open to new patients)
Tobacco (1 in progress, 1 open to new patients)
Tracheal Carcinoma (1 in progress, 1 open to new patients)
Transitional Cell Carcinoma (31 in progress, 31 open to new patients)
Transplants (18 in progress, 18 open to new patients)
Transthyretin-Mediated Amyloidosis (1 in progress, 1 open to new patients)
Trauma (1 in progress, 1 open to new patients)
Trichilemmal Carcinoma (1 in progress, 1 open to new patients)
Tuberous Sclerosis (1 in progress, 1 open to new patients)
Tumors (1 in progress, 1 open to new patients)
Tumor Metastasis (1 in progress, 1 open to new patients)
Tumor Neck (1 in progress, 1 open to new patients)
Tumor Recurrence (1 in progress, 1 open to new patients)
Unresectable Chordoma (1 in progress, 1 open to new patients)
Unresectable Lung Small Cell Carcinoma (1 in progress, 1 open to new patients)
Unresectable Malignant Solid Neoplasm (2 in progress, 2 open to new patients)
Unresectable Solid Neoplasm (1 in progress, 1 open to new patients)
Unresectable Thymic Carcinoma (1 in progress, 1 open to new patients)
Ureter Small Cell Carcinoma (1 in progress, 1 open to new patients)
Ureteral Cancer (4 in progress, 4 open to new patients)
Urethral Adenocarcinoma (1 in progress, 1 open to new patients)
Urethral Cancer (3 in progress, 3 open to new patients)
Urethral Neoplasms (1 in progress, 1 open to new patients)
Urge Incontinence (1 in progress, 1 open to new patients)
Urinary Bladder Tumor (4 in progress, 4 open to new patients)
Urinary Calculi (1 in progress, 1 open to new patients)
Urinary Frequency (1 in progress, 1 open to new patients)
Urinary Incontinence (1 in progress, 1 open to new patients)
Urinary Stones (1 in progress, 1 open to new patients)
Urinary Tract Infection (1 in progress, 1 open to new patients)
Urinary Urgency (1 in progress, 1 open to new patients)
Urogenital Neoplasms (1 in progress, 1 open to new patients)
Urologic Neoplasms (2 in progress, 2 open to new patients)
Uterine Cancer (7 in progress, 7 open to new patients)
Uterine Fibroids (1 in progress, 1 open to new patients)
Uterine Neoplasms (1 in progress, 1 open to new patients)
Vaccine (6 in progress, 6 open to new patients)
Vaginal Adenocarcinoma (1 in progress, 1 open to new patients)
Vomiting in Infants and/or Children (1 in progress, 1 open to new patients)
Vulvar Cancer (1 in progress, 1 open to new patients)
Vulvar Carcinoma (2 in progress, 2 open to new patients)
Waldenstrom Macroglobulinemia (6 in progress, 6 open to new patients)
Weight Management (1 in progress, 1 open to new patients)
Wilms Tumor (9 in progress, 9 open to new patients)

Browse Clinical Trials (1003 trials open to new patients)

Blood, Heart, and Circulation (189 trials open to new patients)

Bones, Joints, and Muscles (41 trials open to new patients)

Brain and Nerves (102 trials open to new patients)

Cancers (1003 trials open to new patients)

Children and Teenagers (2 trials open to new patients)

Diabetes Mellitus (4 trials open to new patients)

Diagnostic Tests (7 trials open to new patients)

Digestive System (206 trials open to new patients)

Drug Therapy (59 trials open to new patients)

Ear, Nose, and Throat (78 trials open to new patients)

Endocrine System (106 trials open to new patients)

Eyes and Vision (6 trials open to new patients)

Fitness and Exercise (1 trial open to new patients)

Food and Nutrition (11 trials open to new patients)

Genetics/Birth Defects (26 trials open to new patients)

Health System (1 trial open to new patients)

Immune System (282 trials open to new patients)

Infections (38 trials open to new patients)

Injuries and Wounds (8 trials open to new patients)

Kidneys and Urinary System (109 trials open to new patients)

Lungs and Breathing (193 trials open to new patients)

Mental Health and Behavior (54 trials open to new patients)

Metabolic Problems (8 trials open to new patients)

Mouth and Teeth (54 trials open to new patients)

Older Adults (106 trials open to new patients)

Poisoning, Toxicology, Environmental Health (1 trial open to new patients)

Population Groups (1 trial open to new patients)

Pregnancy and Reproduction (58 trials open to new patients)

Reproductive System (258 trials open to new patients)

Sexual Health Issues (9 trials open to new patients)

Skin, Hair, and Nails (60 trials open to new patients)

Substance Abuse Problems (3 trials open to new patients)

Surgery and Rehabilitation (51 trials open to new patients)

Symptoms (6 trials open to new patients)

Transplantation and Donation (38 trials open to new patients)

Other (170 trials open to new patients)

Browse Clinical Trials (1003 trials open to new patients)

Blood, Heart, and Circulation (189 trials open to new patients)

Bones, Joints, and Muscles (41 trials open to new patients)

Brain and Nerves (102 trials open to new patients)

Cancers (1003 trials open to new patients)

Children and Teenagers (2 trials open to new patients)

Diabetes Mellitus (4 trials open to new patients)

Diagnostic Tests (7 trials open to new patients)

Digestive System (206 trials open to new patients)

Drug Therapy (59 trials open to new patients)

Ear, Nose, and Throat (78 trials open to new patients)

Endocrine System (106 trials open to new patients)

Eyes and Vision (6 trials open to new patients)

Fitness and Exercise (1 trial open to new patients)

Food and Nutrition (11 trials open to new patients)

Genetics/Birth Defects (26 trials open to new patients)

Health System (1 trial open to new patients)

Immune System (282 trials open to new patients)

Infections (38 trials open to new patients)

Injuries and Wounds (8 trials open to new patients)

Kidneys and Urinary System (109 trials open to new patients)

Lungs and Breathing (193 trials open to new patients)

Mental Health and Behavior (54 trials open to new patients)

Metabolic Problems (8 trials open to new patients)

Mouth and Teeth (54 trials open to new patients)

Older Adults (106 trials open to new patients)

Poisoning, Toxicology, Environmental Health (1 trial open to new patients)

Population Groups (1 trial open to new patients)

Pregnancy and Reproduction (58 trials open to new patients)

Reproductive System (258 trials open to new patients)

Sexual Health Issues (9 trials open to new patients)

Skin, Hair, and Nails (60 trials open to new patients)

Social/Family Issues (4 trials open to new patients)

Substance Abuse Problems (3 trials open to new patients)

Surgery and Rehabilitation (51 trials open to new patients)

Symptoms (6 trials open to new patients)

Transplantation and Donation (38 trials open to new patients)

Other (170 trials open to new patients)